OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
173658

Johnson Health Tech Co Ltd

Recreational ProductsVerified

Capital Structure and Liquidity Johnson Health Tech maintains a debt-to-equity ratio of 1.4, indicating a moderate reliance on debt financing. The company's liquidity is assessed as medium, with a current ratio of 1.37, suggesting it can cover short-term obligations but with limited buffer. Free cash flow for the period was TWD 1.47 billion, while capital expenditures amounted to TWD 1.71 billion, indicating a net cash outflow from operations. ### Profitability and Returns The company's return on equity (ROE) of 20.03% and return on assets (ROA) of 5.48% suggest strong profitability relative to equity but moderate efficiency in asset utilization. These metrics are to be compared against the industry's preferred metrics, which typically emphasize gross margin and operating margin as key indicators of performance. ### Segments and Geographic Exposure The company's revenue is concentrated in the fitness equipment segment, with no disclosed geographic breakdown in the provided data. This lack of diversification may expose the company to regional economic fluctuations. ### Growth Trajectory The company's revenue for the period was TWD 54.33 billion, with a gross profit of TWD 27.47 billion. While the company has demonstrated profitability, the outlook for the current and next fiscal years is not explicitly provided in the data. ### Risk Factors The company faces a medium liquidity risk, as indicated by the current ratio and the negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. ### Recent Events No specific recent events, such as filings or transcripts, are detailed in the provided data to indicate any material changes in the company's operations or strategy.

30-day price · 1736(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyJohnson Health Tech Co Ltd
Ticker1736.TW
SectorConsumer Cyclicals
BusinessCyclical Consumer Products
Industry groupCyclical Consumer Products
IndustryRecreational Products
AI analysis

Business. Johnson Health Tech Co Ltd designs, develops, and sells fitness equipment and related products, primarily under the Johnson & Johnson brand, with a focus on home and commercial fitness markets.

Classification. The company is classified under the industry "Recreational Products" within the "Cyclical Consumer Products" business sector, with a confidence level of 0.92.

### Capital Structure and Liquidity Johnson Health Tech maintains a debt-to-equity ratio of 1.4, indicating a moderate reliance on debt financing. The company's liquidity is assessed as medium, with a current ratio of 1.37, suggesting it can cover short-term obligations but with limited buffer. Free cash flow for the period was TWD 1.47 billion, while capital expenditures amounted to TWD 1.71 billion, indicating a net cash outflow from operations. ### Profitability and Returns The company's return on equity (ROE) of 20.03% and return on assets (ROA) of 5.48% suggest strong profitability relative to equity but moderate efficiency in asset utilization. These metrics are to be compared against the industry's preferred metrics, which typically emphasize gross margin and operating margin as key indicators of performance. ### Segments and Geographic Exposure The company's revenue is concentrated in the fitness equipment segment, with no disclosed geographic breakdown in the provided data. This lack of diversification may expose the company to regional economic fluctuations. ### Growth Trajectory The company's revenue for the period was TWD 54.33 billion, with a gross profit of TWD 27.47 billion. While the company has demonstrated profitability, the outlook for the current and next fiscal years is not explicitly provided in the data. ### Risk Factors The company faces a medium liquidity risk, as indicated by the current ratio and the negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. ### Recent Events No specific recent events, such as filings or transcripts, are detailed in the provided data to indicate any material changes in the company's operations or strategy.
Key takeaways
  • Johnson Health Tech has a strong ROE of 20.03% but a moderate ROA of 5.48%, indicating strong profitability relative to equity.
  • The company's debt-to-equity ratio of 1.4 suggests a moderate reliance on debt financing.
  • Free cash flow was TWD 1.47 billion, but capital expenditures exceeded this amount, leading to a net cash outflow.
  • The company's liquidity is assessed as medium, with a current ratio of 1.37.
  • The company's revenue is concentrated in the fitness equipment segment, with no geographic diversification disclosed.
  • Analysts have a positive outlook, with a mean price target of TWD 212.00 and a mean recommendation of 1.33 (strong buy to buy).
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$54.33B
Gross profit$27.47B
Operating income$3.59B
Net income$2.75B
R&D
SG&A
D&A
SBC
Operating cash flow$2.58B
CapEx-$1.71B
Free cash flow$1.47B
Total assets$50.13B
Total liabilities$36.40B
Total equity$13.73B
Cash & equivalents
Long-term debt$19.16B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$13.73B
Net cash-$19.16B
Current ratio1.4
Debt/Equity1.4
ROA5.5%
ROE20.0%
Cash conversion94.0%
CapEx/Revenue-3.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Recreational Products · cohort 1 companies
Metric1736Activity
Op margin6.6%-0.8% medp25 -0.8% · p75 -0.8%top quartile
Net margin5.1%-2.6% medp25 -2.6% · p75 -2.6%top quartile
Gross margin50.6%27.7% medp25 17.4% · p75 41.4%top quartile
R&D / revenue3.1% medp25 3.1% · p75 3.1%
CapEx / revenue-3.1%3.1% medp25 3.1% · p75 3.1%bottom quartile
Debt / equity140.0%111.1% medp25 111.1% · p75 111.1%top quartile
Observations
IR observations
Mean price target212.00 TWD
Median price target212.00 TWD
High price target235.00 TWD
Low price target189.00 TWD
Mean recommendation1.33 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate11.98 TWD
Last actual EPS9.06 TWD
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 20:02 UTCJob: c417508e